AAM
TECH icon

Arabesque Asset Management’s Bio-Techne TECH Stock Holding History

Arabesque Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,656
Closed -$1.18M – 141
2022
Q2 		$1.18M Sell
13,656
-1,080
-7% -$101K 0.62% 86
2022
Q1 		$1.59M Sell
14,736
-800
-5% -$82.5K 0.55% 96
2021
Q4 		$2.01M Buy
+15,536
New +$1.9M 0.58% 89

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Arabesque Asset Management's TECH Position: Q3 2022 in Review

Arabesque Asset Management sold out of Bio-Techne (TECH) in Q3 2022, closing a stake of 13,656 shares — an estimated $1.18M sold.

Arabesque Asset Management first reported a position in TECH in Q4 2021 and held it in 3 quarters. The position peaked at $2.01M in Q4 2021. 536 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

  • Arabesque Asset Management reported no remaining Bio-Techne position as of Q3 2022 after selling out during the quarter.
  • Arabesque Asset Management sold 13,656 Bio-Techne shares in Q3 2022, an estimated $1.18M.
  • Arabesque Asset Management first reported a position in Bio-Techne in Q4 2021 and held it in 3 quarters.
  • Arabesque Asset Management's Bio-Techne position peaked at $2.01M in Q4 2021.
  • 536 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on Arabesque Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.